ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Nephrotrans®:Salmon Pharma GmbH
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
A02AH - Antacids with Sodium BicarbonateATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A02 - Drugs for Acid Related Disorders
 
A02A - Antacids

This group comprises plain antacid drugs, antacids in combination with antiflatulents and antacids in combination with other drugs.
Antacids in combination with liquorice root or linseed are classified in this group.
Plain antiflatulents, see A03AX - Other drugs for functional gastrointestinal disorders.

The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus. One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.
For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).

A02AH - Antacids with Sodium Bicarbonate

No ATC 5th levels are assigned in this group.
All oral formulations containing sodium bicarbonate including products indicated for metabolic acidosis are classified in this group.
Parenteral formulations, see B05BB.
Combinations of sodium bicarbonate and proton pump inhibitors are classified in A02BC.
Preparations containing sodium bicarbonate to be used only in connection with double-contrast radiography are classified in V07AY.

2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home